Opportunity Information: Apply for RFA RM 12 023
Apply for RFA RM 12 023
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Diffusion of Medical Technology and Effects on Outcomes and Expenditures (U01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.310 Trans NIH Research Support.
- This funding opportunity was created on Nov 16, 2012 and posted on Nov 16, 2012.
- Applicants must submit their applications by Feb 28, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $2,700,000.00 to eligible and selected applicants.
- Eligible applicants include: Small businesses Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Special district governments Public housing authorities/Indian housing authorities State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Independent school districts Private institutions of higher education City or township governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NIH grant opportunity titled "Diffusion of Medical Technology and Effects on Outcomes and Expenditures (U01)" (Funding Opportunity Number RFA-RM-12-023) was a discretionary funding announcement aimed at supporting economic research that explains how medical and health technologies spread into real-world practice and how that spread affects both patient outcomes and health care spending. The core purpose was not simply to study whether a technology works in a clinical sense, but to understand the broader process by which scientific advances move from discovery to adoption, and how that adoption pattern shapes trends in population health and costs. In other words, the emphasis is on technology diffusion: why some innovations take off quickly while others do not, what factors influence uptake across different providers and patient groups, and what the downstream consequences are for quality of care, utilization, and expenditures.
This opportunity used the U01 cooperative agreement mechanism, which typically indicates a more active partnership between NIH and the funded research teams than a standard research grant. A key feature of this FOA is that funded Program Directors/Principal Investigators were required to participate in a Steering Committee. That committee was intended to coordinate and strengthen the overall research agenda by helping to identify important cross-cutting strategies and priority questions that would accelerate progress in understanding diffusion and its economic and health impacts. Practically, that requirement signals that awardees should expect collaborative planning, shared discussions about methods and data, and alignment around major research gaps in the field.
The funding instrument was categorized under the Health activity area and carried CFDA number 93.310 (Trans-NIH Research Support). The FOA listed an estimated total funding amount of $2,700,000 and stated that there was no cost sharing or matching requirement. The announcement was posted and created on November 16, 2012, with an original and current closing date of February 28, 2013, and it was archived on March 31, 2013. While the dates indicate this was a time-limited solicitation, the details reflect a structured NIH effort to build an evidence base around how new medical technologies influence spending growth and health outcomes at scale, beyond narrow clinical effectiveness questions.
Eligibility was broad and inclusive, spanning many organizational types across the public, private, nonprofit, and academic sectors. Eligible applicants included small businesses; for-profit organizations (including those other than small businesses); nonprofit organizations with or without 501(c)(3) status; public and private institutions of higher education; and a range of government entities such as state governments, county governments, city or township governments, special district governments, independent school districts, and public housing authorities/Indian housing authorities. The FOA also explicitly included Native American tribal governments (federally recognized) and tribal organizations (including those other than federally recognized tribal governments), as well as tribally controlled colleges and universities (TCCUs). It further highlighted eligibility for institutions serving specific populations, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, and Asian American Native American Pacific Islander-serving institutions (AANAPISIs). Faith-based and community-based organizations, regional organizations, and eligible federal agencies were also included.
Notably, the NIH allowed participation by non-U.S. entities and components. Non-domestic (non-U.S.) organizations and foreign institutions were eligible to apply, non-domestic components of U.S. organizations were eligible, and foreign components (as defined under the NIH Grants Policy Statement) were allowed. This openness suggests the research questions were seen as globally relevant and that comparative work or international expertise could strengthen understanding of diffusion dynamics, especially where health systems differ and can illuminate how policy, payment, and regulation affect adoption and spending.
Administrative details and access information were provided through NIH, with an additional information link pointing to the full FOA on the NIH Grants Guide website. For access issues, the contact listed was the NIH Office of Extramural Research (OER) webmaster, with guidance for both difficulties accessing the announcement and problems linking to the funding posting. Overall, the opportunity sought to build rigorous economic evidence on the real-world pathways that determine whether medical technologies translate into better health, higher costs, or both, and to use that evidence to improve the efficiency and impact of the innovation-to-benefit pipeline.
Frequently Asked Questions (FAQs)
What is the title and funding opportunity number for this NIH grant?
The opportunity is titled "Diffusion of Medical Technology and Effects on Outcomes and Expenditures (U01)" and the Funding Opportunity Number is RFA-RM-12-023.
What is the main purpose of this funding opportunity?
The purpose is to support economic research that explains how medical and health technologies spread (diffuse) into real-world practice and how that diffusion affects patient outcomes and health care spending.
Is this opportunity focused on clinical effectiveness (whether a technology works clinically)?
No. The emphasis is not simply on whether a technology works in a clinical sense, but on the broader process of discovery-to-adoption and how adoption patterns shape trends in population health and costs.
What does "technology diffusion" mean in the context of this FOA?
In this FOA, technology diffusion refers to how innovations are adopted in real-world health care settings, including why some innovations are taken up quickly while others are not, what factors influence uptake across providers and patient groups, and what the downstream consequences are for quality of care, utilization, and expenditures.
What funding mechanism does this opportunity use?
This FOA uses the U01 cooperative agreement mechanism.
What does the U01 cooperative agreement imply for the relationship with NIH?
The U01 mechanism typically indicates a more active partnership between NIH and funded research teams than a standard research grant, including coordinated activities and collaboration expectations described in the FOA.
Are awardees required to participate in any coordinated group or governance structure?
Yes. Funded Program Directors/Principal Investigators are required to participate in a Steering Committee.
What is the purpose of the required Steering Committee?
The Steering Committee is intended to coordinate and strengthen the overall research agenda by helping identify cross-cutting strategies and priority questions that accelerate progress in understanding diffusion and its economic and health impacts.
What should awardees expect in practical terms due to the Steering Committee requirement?
Awardees should expect collaborative planning, shared discussions about methods and data, and alignment around major research gaps in the field.
What activity area is this funding opportunity associated with?
The funding instrument is categorized under the Health activity area.
What CFDA number is associated with this opportunity?
The CFDA number listed is 93.310 (Trans-NIH Research Support).
What is the estimated total funding amount for this FOA?
The FOA listed an estimated total funding amount of $2,700,000.
Is cost sharing or matching required?
No. The FOA stated there was no cost sharing or matching requirement.
When was the announcement posted/created?
The announcement was posted and created on November 16, 2012.
What was the closing date for applications?
The original and current closing date was February 28, 2013.
Is this funding opportunity still active?
No. The FOA was archived on March 31, 2013, and the listed closing date was February 28, 2013.
What types of organizations were eligible to apply?
Eligibility was broad and included small businesses; for-profit organizations (including those other than small businesses); nonprofit organizations with or without 501(c)(3) status; public and private institutions of higher education; and multiple types of government entities.
Which government entities were eligible?
Eligible government entities included state governments, county governments, city or township governments, special district governments, independent school districts, and public housing authorities/Indian housing authorities.
Were Native American tribal governments and tribal organizations eligible?
Yes. The FOA explicitly included Native American tribal governments (federally recognized) and tribal organizations, including those other than federally recognized tribal governments.
Were tribally controlled colleges and universities (TCCUs) eligible?
Yes. Tribally controlled colleges and universities (TCCUs) were included in the eligibility list.
Did the FOA include institutions serving specific populations (for example, HBCUs or Hispanic-serving institutions)?
Yes. The FOA highlighted eligibility for Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, and Asian American Native American Pacific Islander-serving institutions (AANAPISIs).
Were faith-based and community-based organizations eligible?
Yes. Faith-based and community-based organizations were included as eligible applicants.
Were regional organizations eligible?
Yes. Regional organizations were included as eligible applicants.
Were federal agencies eligible to apply?
Yes. The FOA included eligible federal agencies.
Could non-U.S. (foreign) organizations apply?
Yes. Non-domestic (non-U.S.) organizations and foreign institutions were eligible to apply.
Could non-domestic components of U.S. organizations participate?
Yes. Non-domestic components of U.S. organizations were eligible.
Are foreign components allowed under this FOA?
Yes. Foreign components (as defined under the NIH Grants Policy Statement) were allowed.
Where could applicants find the full FOA details?
The FOA indicated an additional information link to the full announcement on the NIH Grants Guide website.
Who was listed as the contact for access issues with the announcement?
The contact listed for access issues was the NIH Office of Extramural Research (OER) webmaster, with guidance covering difficulties accessing the announcement and problems linking to the funding posting.
What overall research aim was NIH trying to advance with this solicitation?
The opportunity reflects a structured NIH effort to build an evidence base on how new medical technologies influence spending growth and health outcomes at scale, focusing on the real-world pathways that determine whether technologies translate into better health, higher costs, or both.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: U.S. Russia Bilateral Collaborative Research Partnerships (CRP) on the Prevention and Treatment of HIV/AIDS and Co morbidities (R21)
Previous opportunity: Great Lakes Areas of Concern Land Acquisition Grants
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA RM 12 023
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA RM 12 023) also looked into and applied for these:
| Funding Opportunity |
|---|
| Enhancing GTEx with molecular analyses of stored biospecimens (U01) Apply for RFA RM 12 009 Funding Number: RFA RM 12 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Cooperative Program in Translational Research (U01) Apply for PAR 13 022 Funding Number: PAR 13 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Exploratory/Developmental Projects in Translational Research (R21) Apply for PAR 13 023 Funding Number: PAR 13 023 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Determinants and Consequences of Personalized Health Care and Prevention (U01) Apply for RFA RM 12 024 Funding Number: RFA RM 12 024 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Trans Agency Research Consortium for Trauma Induced Coagulopathy (TACTIC) (UM1) Apply for RFA HL 13 025 Funding Number: RFA HL 13 025 Agency: National Institutes of Health Category: Health Funding Amount: $4,800,000 |
| NIDCD Research Core Centers (P30) Apply for PAR 13 024 Funding Number: PAR 13 024 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Affordable Care Act Maternal, Infant and Early Childhood Home Visiting Program Grants to Nonprofit Organizations Apply for HRSA 13 255 Funding Number: HRSA 13 255 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Centers of Excellence for Translational Research (CETR) (U19) Apply for RFA AI 12 044 Funding Number: RFA AI 12 044 Agency: National Institutes of Health Category: Health Funding Amount: $4,000,000 |
| Morris K. Udall Centers of Excellence for Parkinsons Disease Research (P50) Apply for RFA NS 13 006 Funding Number: RFA NS 13 006 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Selected Topics in Transfusion Medicine (R21) Apply for PAR 13 025 Funding Number: PAR 13 025 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Selected Topics in Transfusion Medicine (R01) Apply for PAR 13 026 Funding Number: PAR 13 026 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Health Workforce Research Center (HWRC) Program Apply for HRSA 13 185 Funding Number: HRSA 13 185 Agency: Health Resources and Services Administration Category: Health Funding Amount: $500,000 |
| Nurse Education, Practice, Quality and Retention (NEPQR) Program Interprofessional Collaborative Practice Apply for HRSA 13 188 Funding Number: HRSA 13 188 Agency: Health Resources and Services Administration Category: Health Funding Amount: $500,000 |
| HIV Early Intervention Services (EIS) Program Existing Geographic Service Areas (EISEGA) Apply for HRSA 13 168 Funding Number: HRSA 13 168 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Community Based Dental Partnership Program Apply for HRSA 13 170 Funding Number: HRSA 13 170 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Natural History and Prevention of Viral Hepatitis Among Alaska Natives Apply for RFA PS 13 001 Funding Number: RFA PS 13 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Advanced Nursing Education Program Apply for HRSA 13 186 Funding Number: HRSA 13 186 Agency: Health Resources and Services Administration Category: Health Funding Amount: $375,000 |
| Communication for Healthy Communities Apply for RFA 617 13 000001 Funding Number: RFA 617 13 000001 Agency: Uganda USAID Kampala Category: Health Funding Amount: $50,000,000 |
| Medical Home Implementation for Children with Special Health Care Needs Apply for HRSA 13 216 Funding Number: HRSA 13 216 Agency: Health Resources and Services Administration Category: Health Funding Amount: $800,031 |
| National Center on Health Care Transition for Youth with Special Health Care Needs Apply for HRSA 13 218 Funding Number: HRSA 13 218 Agency: Health Resources and Services Administration Category: Health Funding Amount: $436,160 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA RM 12 023", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.